Skip to content

Genetic insights into childhood obesity: A comprehensive bioinformatics analysis

Jul 2026 · Journal of environmental biology · Vol 47, pp. 949-956 · 0 citations

TL;DR

A comprehensive genetic and molecular landscape underlying childhood obesity is delineated, reflecting its multifactorial pathogenesis, with implications for improving future prevention and management strategies for childhood obesity.

Abstract

Aim: This study aimed to explore the genetic basis of childhood obesity through systematic identification and examination of genes, pathways, and regulatory elements contributing to disease development using integrated bioinformatic approaches. Methodology: Thirty genes strongly associated with childhood obesity were subjected to detailed computational analysis using DisGeNET, Gene Ontology (GO), and WikiPathways. Gene–gene interaction patterns, biological processes, molecular functions, and cellular components were examined. Regulatory layers involving transcription factor and microRNA interactions were additionally analysed to characterise genetic and post-transcriptional control mechanisms. Results: Significantly enriched pathways included adipogenesis, orexin receptor signalling, hunger and satiety regulation, and broader metabolic control mechanisms. Key genes including LEP, IL6, POMC and ADIPOQ recurred across multiple analyses, indicating central roles within obesity-associated molecular networks. Cross-database integration revealed complex genetic interactions and molecular cross-talk influencing obesity-related phenotypes. Interpretation: This study delineates a comprehensive genetic and molecular landscape underlying childhood obesity, reflecting its multifactorial pathogenesis. The identification of key regulatory genes, transcription factors, and microRNA interactions provides valuable insight into potential molecular targets, with implications for improving future prevention and management strategies for childhood obesity. Key words: Bioinformatics, Childhood obesity, Gene pathways, Molecular networks, Therapeutic targets

View source

Similar papers

Open access Aug 2026

Unraveling the pathogenic mechanisms of osteoarthritis and obesity: An integration of GWAS, cellular specificity, and spatial transcriptomics

This study precisely anchors the genetic risk of OA and obesity to specific brain regions, cell types, and developmental time windows, providing a novel perspective for understanding the pathological mechanisms of OA.

Ze-Hong Lin, Ji-Hui Wei, Hong-Hai Zhou · 0 citations
Open access Jul 2026

GENOMIC INSIGHTS INTO CHRONIC DISEASE SUSCEPTIBILITY: IMPLICATIONS FOR PERSONALISED MEDICINE

It is demonstrated that genomic susceptibility is organised into biologically distinct profiles defined by coordinated variant, gene, pathway, and cumulative risk signals, which provides a practical basis for risk stratification and supports the application of genomics in personalised medicine.

Bana Sarahbibi Mohmedsalim, Subhabrata Sarkar, Sukanta Bandyopadhyay et al. · 0 citations
Open access Aug 2026

Common genetic mechanisms between obesity and COVID-19 severity: unravelling pleiotropic loci and biological pathways

A biologically meaningful genetic overlap between obesity and COVID-19 severity is suggested, highlighting pleiotropy as a key feature in complex disease interactions and potential shared therapeutic targets.

Giulia Souza da Costa, C. Bandeira, Nicolas Pereira Ciochetti et al. · 0 citations
Sep 2026

Integrated bioinformatics and SEM analysis reveal GPAM as a key mediator of fibrosis in NAFLD with metabolic dysfunction

The first genetically grounded mechanism for the progression of NAFLD to fibrosis is presented, which encompasssses genetic variants, dysregulated gene expression, metabolic disturbances, and the processes involved in fibrotic remodeling.

B. Peng, Meng-Ying Xu, Li Ma et al. · 0 citations
Open access Aug 2026

Key genetic biomarkers and therapeutic potential in multiple sclerosis: Insights from integrated bioinformatics and mendelian randomization.

This study integrates transcriptomic, genetic-causal, immunological, and structural analyses to prioritize STAT6 as a potentially druggable MS-associated target and strengthen the computational plausibility of STAT6-ligand interactions.

Zhongbo Xu, Ke Xiong, Dan Zhao · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.